Updates
GENEGUT Behind the Scenes: CarboHyde
Welcome to the next edition of our “GENEGUT: Behind the Scenes” series — where we spotlight the passionate teams driving innovation across the GENEGUT project. Today, we introduce CarboHyde, based in Budapest, Hungary.
GENEGUT: From Lab to Life – Modeling IBD in vitro: a tool to foster innovative therapeutics translation
Our improved 3D model plays a big role in the GENEGUT project as a testing platform to check if the new nano-based treatments we’re developing are safe and effective in IBD treatment.
GENEGUT Behind the Scenes: I3S – Institute of Science and Innovation in Health, University of Porto
Welcome to the next edition of our “GENEGUT: Behind the Scenes” series — where we spotlight the passionate teams driving innovation across the GENEGUT project. Today, we introduce i3S – Institute of Science and Innovation in Health, based in Porto, Portugal.
Voices of GENEGUT: Reflections for World IBD Day 2025
To mark World IBD Day 2025, the GENEGUT project is proud to share a special interview featuring voices from across the IBD community. This year’s campaign, “IBD Has No Borders: Breaking Taboos, Talking About It”, launched by EFCCA, GENEGUT’s project partner, shines a spotlight on the ongoing stigma and silence that many people living with IBD still face today.
GENEGUT: From Lab to Life – The Next Step in Drug Delivery: Smart Capsules
Our recent review explored the state of the art in smart capsule design, from power supplies and release mechanisms to localisation strategies and future materials. While hurdles remain, ongoing innovation is rapidly bringing this technology closer to real-world application.
Exploring Patient Perspectives on Diet and IBD: A Publication from UCC Researchers
While not part of the GENEGUT project itself, a recent publication by researchers from University College Cork (UCC) — a GENEGUT project coordinator — closely aligns with GENEGUT’s mission to explore the role of the gut in chronic disease and innovate therapeutic strategies.